← Browse by Condition
Medical Condition
transformed follicular lymphoma tfl
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT06014762 Phase 1
Recruiting
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Enrollment
120 pts
Location
United States
Sponsor
Poseida Therapeutics, Inc.
NCT07473167 Phase 1, Phase 2
Recruiting
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Enrollment
98 pts
Location
South Korea
Sponsor
TICAROS Co., Ltd.